Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

SNAP 101: Randomized, Crossover, Active and Placebo-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of 3 Ascending Doses of Olanzapine delivered by the Novel Precision Olfactory Delivery (POD®) Device

An estimated 1.7 million acute agitation events occur annually; OLZ IM is a preferred option due to a shorter Tmax than oral, but IM administration, predominantly administered in a hospital setting, can be painful, humiliating, invasive, and requires cooperation or…

SNAP 101: Randomized, Crossover, Active/Placebo- Controlled, Safety and PK/PD Study of 3 Ascending Doses of POD® Olanzapine

A survey of US Emergency Department (ED) staff in 2008 found 65% had witnessed physical attacks, 32% reported ?1 verbal threat per day and 18% had been assaulted once or more with a weapon but only 40% of EDs trained…

A History of Dihydroergotamine in Migraine

This work provides a history of dihydroergotamine (DHE) treatment from its synthesis in 1943 from ergotamine to modern day formulations and routes of administration.

25 26 27